Document is current

Article History

Received: 17 December 2024

Accepted: 21 March 2025

First Online: 22 April 2025

Declarations

:

: Arash Mostaghimi declares receiving personal fees from Hims & Hers Health, AbbVie, SUN Pharma, Pfizer, Digital Diagnostics, Lilly, Equillium, ASLAN Pharmaceuticals, Boehringer Ingelheim, Acom Healthcare, Olaplex, and Legacy Healthcare. Adam Gibson, Georges Dwyer, and Yemi Oluboyede are employees of Putnam Associates, an independent life sciences consultancy, who were employed by Pfizer to undertake this study. Iyar Mazar and Ernest Law are employees of Pfizer Inc and may own stock and/or options. Kristina Gorbatenko-Roth declares receiving research and/or consulting fees from Pfizer, National Alopecia Areata Foundation, and Procter & Gamble.

: Participants provided written inform consent prior to entering the study. The study protocol and all participant-facing documentation, including the interview discussion guide, were reviewed by an independent, USA-based ethics review board (Advarra, Inc., Columbia, MD, USA), which deemed the study to be exempt from institutional review board oversight. The study was conducted in accordance with legal and regulatory requirements, as well as with scientific purpose, value, and rigor, and followed generally accepted research practices described in British Healthcare Business Intelligence Association guidelines, UK Data Protection Act 2018, General Data Protection Regulation, and relevant legislations pertaining to data privacy for US participants.